4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane

C50H52N6O2+4 — CID 157123851

IUPAC4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane
SMILESC.Cc1cc(-c2ccccc2CCCn2cc[n+](C)c2)cc2c1OC13Oc4c(C)cc(-c5ccccc5CCCn5cc[n+](C)c5)cc4C=[N+]1c1ccccc1[N+]3=C2
InChIInChI=1S/C49H48N6O2.CH4/c1-35-27-39(43-17-7-5-13-37(43)15-11-21-52-25-23-50(3)33-52)29-41-31-54-45-19-9-10-20-46(45)55-32-42-30-40(28-36(2)48(42)57-49(54,55)56-47(35)41)44-18-8-6-14-38(44)16-12-22-53-26-24-51(4)34-53;/h5-10,13-14,17-20,23-34H,11-12,15-16,21-22H2,1-4H3;1H4/q+4;
InChIKeyPPASFILIGMIFIW-UHFFFAOYSA-N
MW769.01 g/mol
LogP8.73
Rot. Bonds10

About 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane

4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane (PubChem CID 157123851) has the molecular formula C50H52N6O2+4 and a molecular weight of 769.01 g/mol. Its IUPAC name is 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane.

Molecular Properties

Compound Name4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane
PubChem CID157123851
Molecular FormulaC50H52N6O2+4
Molecular Weight769.01 g/mol
Exact Mass768.41
IUPAC Name4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane
SMILESC.Cc1cc(-c2ccccc2CCCn2cc[n+](C)c2)cc2c1OC13Oc4c(C)cc(-c5ccccc5CCCn5cc[n+](C)c5)cc4C=[N+]1c1ccccc1[N+]3=C2
InChIInChI=1S/C49H48N6O2.CH4/c1-35-27-39(43-17-7-5-13-37(43)15-11-21-52-25-23-50(3)33-52)29-41-31-54-45-19-9-10-20-46(45)55-32-42-30-40(28-36(2)48(42)57-49(54,55)56-47(35)41)44-18-8-6-14-38(44)16-12-22-53-26-24-51(4)34-53;/h5-10,13-14,17-20,23-34H,11-12,15-16,21-22H2,1-4H3;1H4/q+4;
InChIKeyPPASFILIGMIFIW-UHFFFAOYSA-N
XLogP8.73
TPSA42.10 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds10
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500769.01
LogP ≤ 58.73
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane?
The IUPAC name of 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane (CID 157123851) is 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane.
What is the SMILES notation for 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane?
The canonical SMILES for 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane is C.Cc1cc(-c2ccccc2CCCn2cc[n+](C)c2)cc2c1OC13Oc4c(C)cc(-c5ccccc5CCCn5cc[n+](C)c5)cc4C=[N+]1c1ccccc1[N+]3=C2.
What is the InChIKey of 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane?
The InChIKey is PPASFILIGMIFIW-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H48N6O2.CH4/c1-35-27-39(43-17-7-5-13-37(43)15-11-21-52-25-23-50(3)33-52)29-41-31-54-45-19-9-10-20-46(45)55-32-42-30-40(28-36(2)48(42)57-49(54,55)56-47(35)41)44-18-8-6-14-38(44)16-12-22-53-26-24-51(4)34-53;/h5-10,13-14,17-20,23-34H,11-12,15-16,21-22H2,1-4H3;1H4/q+4;.
What are the key properties of 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane?
4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane has a molecular weight of 769.01 g/mol, XLogP of 8.73, 10 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4,23-dimethyl-6,21-bis[2-[3-(3-methylimidazol-3-ium-1-yl)propyl]phenyl]-2,25-dioxa-10,17-diazoniahexacyclo[15.8.0.01,10.03,8.011,16.019,24]pentacosa-3(8),4,6,9,11,13,15,17,19(24),20,22-undecaene;methane is sourced from PubChem (CID 157123851), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).